Katherine T. Marcucci

Statistics

Publications

Citations

3.4K

H-Index

Active since

2006

Affiliations

University of Pennsylvania(Current)

Children's Hospital of Philadelphia

UPMC Hillman Cancer Center

Novartis (United States)

Novartis (Switzerland)

Katherine T. Marcucci is an author at University of Pennsylvania specializing in immunotherapy, life sciences, and chimeric antigen receptor t-cell therapy.

Publications per year

2006–2021

Publications

Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia

David Porter, Wei‐Ting Hwang, Noelle V. Frey et al. · Science Translational Medicine · 2015 · 1.7K citations · Full text

Life Sciences, Immunology, Oncology +14

Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells

Joseph A. Fraietta, Christopher L. Nobles, Morgan A. Sammons et al. · Nature · 2018 · 861 citations · Full text

Life Sciences, Cell Biology, Immunology +14

Retroviral and Lentiviral Safety Analysis of Gene-Modified T Cell Products and Infused HIV and Oncology Patients

Katherine T. Marcucci, Julie K. Jadlowsky, Wei‐Ting Hwang et al. · Molecular Therapy · 2017 · 141 citations · Full text

Life Sciences, Immunology, Translational Sciences +17

BET bromodomain protein inhibition reverses chimeric antigen receptor extinction and reinvigorates exhausted T cells in chronic lymphocytic leukemia

Weimin Kong, Alexander J. Dimitri, Wang Wenliang et al. · Journal of Clinical Investigation · 2021 · 94 citations · Full text

Life Sciences, Immunology, Oncology +17

Efficacy of Humanized CD19-Targeted Chimeric Antigen Receptor (CAR)-Modified T Cells in Children and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia

Shannon L. Maude, David M. Barrett, Susan R. Rheingold et al. · Blood · 2016 · 81 citations

Life Sciences, Hematology, Immunology +17

1–5 of 22